Rimegepant for migraine: acute efficacy beyond the USA

Lancet Neurol. 2023 Jun;22(6):456-457. doi: 10.1016/S1474-4422(23)00160-6.
No abstract available

Publication types

  • Comment

MeSH terms

  • Humans
  • Migraine Disorders* / drug therapy
  • Piperidines* / therapeutic use
  • Pyridines

Substances

  • rimegepant sulfate
  • Piperidines
  • Pyridines